Manshing Global (08309) completes the acquisition of Hong Kong property.

27/12/2024

GMT Eight

MANSHING GLOBAL (08309) announced that the acquisition has been completed on December 27, 2024. After completion, the property will be held by the company through Juncheng Services Limited (a limited company established and registered in Hong Kong, which is an indirect wholly-owned subsidiary of the company).

Hefei Lifeon Pharmaceutical (003020.SZ) Methorphan Hydrochloride raw material drug listing application accepted

Beijing Tiantan Biological Products Corporation (600161.SH): Termination of intravenous COVID-19 human immunoglobulin (pH4) clinical trial.

Contact: contact@gmteight.com

Manshing Global (08309) completes the acquisition of Hong Kong property.

RECOMMEND

According to the 2020 Restricted Share Unit Plan, CHINA LIT (00772) has granted a total of 552,500 restricted share units.

XIZANG ZHUFENG RESOURCES (600338.SH) plans to donate RMB 3.38 million in cash to the earthquake-stricken area in Shigatse, Tibet.

On January 10th, VIVA BIOTECH (01873) spent 252,800 Hong Kong dollars to repurchase 316,000 shares.